MoneyWorks4Me

Ipca Laboratories board to consider Audited Financial Results

06 May 2013 Evaluate

Ipca Laboratories has informed that a meeting of the Board of Directors of the Company will be held on May 30, 2013, to consider the Audited Financial Results for the financial year ended March 31, 2013, and recommendation of final dividend for the financial year ended March 31, 2013.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..